Triamterene

CAS 396-01-0 2 current records 12 historicalSmall Molecule

Who holds supplier records for Triamterene? 2 organisations hold a current record for Triamterene: an active US FDA Type II Drug Master File or a CEP. A further 12 organisations have only historical (inactive) DMF filings. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Italy (1) and Spain (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Triamterene: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/triamterene

Reading the evidence

  • 2 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (2)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Triamterene. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Triamterene sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (2)

Certificates of Suitability on the EDQM register for Triamterene, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 3 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
DIPHARMA FRANCIS S.R.L. BaranzateIT
CEP 2024-567 - Rev 00
Triamterene
Jul 2025Inspected Mar 2025
Italy
Moehs Iberica S.L. RubiES
R1-CEP 1996-038 - Rev 04
Triamterene
Oct 2018—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (12)

Organisations whose Type II DMFs for Triamterene are no longer active. These show a past filing, not current supply.

Show all 12 historical records
  • India · Inactive DMF 24965 · filed Jul 2011
  • FABBRICA ITALIANA SINTETICI SPA
    Inactive DMF 7344 · filed Feb 1988
  • SELOC AG
    Inactive DMF 5553 · filed Oct 1984
  • France · Inactive DMF 4677 · filed Sept 1982
  • PLANTEX LTD CHEMICAL AND PHARMACEUTICAL WORKS
    Inactive DMF 4363 · filed Nov 1981
  • ROUSSELL UCLAF
    Inactive DMF 3787 · filed Apr 1980
  • FARCHEMIA SRL
    Inactive DMF 3806 · filed Mar 1980
  • ACIC LTD
    Inactive DMF 3416 · filed Jan 1979
  • SIEGFRIED AG
    Inactive DMF 3318 · filed Sept 1978
  • SCHARPER SPA
    Inactive DMF 3277 · filed Apr 1978
  • LONZA RIVERSIDE
    Inactive DMF 2586 · filed Dec 1975
  • LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO
    Inactive DMF 600 · filed Jun 1963

Overview

Triamterene is a potassium-sparing diuretic used to treat fluid retention (edema) in patients with congestive heart failure, liver cirrhosis, and nephrotic syndrome. It works by inhibiting sodium reabsorption in the distal convoluted tubules and collecting ducts of the kidneys, which helps prevent potassium loss.

Chemical identity

IUPAC name
6-phenylpteridine-2,4,7-triamine
Canonical SMILES
C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N
InChIKey
FNYLWPVRPXGIIP-UHFFFAOYSA-N
Synonyms
Dyrenium API, dyazide component triamterene, maxzide component triamterene, nsc-639359, nsc-77625, sk&f 8542, sk&f-8542, sk-8542

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Potassium-sparing Diuretic
Physiologic effect
Decreased Renal K+ Excretion; Increased Diuresis

Therapeutic areas

Cardiovascular SystemDiureticsEdema Treatment

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Triamterene?

2 organisations hold an active US FDA Type II Drug Master File or a CEP for Triamterene: Dipharma Francis Srl (Italy) and MOEHS IBERICA SL (Spain). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Triamterene Drug Master Files are active?

Dipharma Francis Srl (DMF 3516) and MOEHS IBERICA SL (DMF 6603, 18757). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Triamterene records mean?

12 organisations have only inactive Type II DMFs for Triamterene. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Triamterene have a European Certificate of Suitability?

Yes. 2 organisations hold a valid CEP for Triamterene on the EDQM register, including DIPHARMA FRANCIS S.R.L. Baranzate (IT) and Moehs Iberica S.L. Rubi (ES). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Triamterene supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Triamterene?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.